Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat in Mild Persistent Asthma
NCT01316380Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Peak Forced Expiratory Volume in 1 Second (FEV1) Response Within 3 Hours Post Dosing. Started Mar 2011; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01316380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316380.